ArticleApplied microbiology and biotechnology2026
The potential of plant-derived triterpenoids as biological nitrification inhibitors.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Comparative Analysis of Ursolic and Oleanolic Acids in ElevenMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Biological nitrification inhibitors (BNIs) present an environmentally friendly approach to reduce nitrogen losses and enhance nitrogen use efficiency, with plant-derived triterpenoids emerging as promising candidates. We evaluated 18 triterpenoids as BNIs using in vitro assays with soil ammonia-oxidizing bacteria (AOB) (Nitrosospira multiformis, Nitrosomonas ureae) and archaea (AOA) (Nitrososphaera viennensis, Nitrosotalea sinensis) at high and low concentrations. A Graph Neural Network framework was applied to predict nitrification inhibition (NI) and identify structural features, including key functional groups, linked to inhibitory patterns. Triterpenoids were more active on AOA, demonstrating higher efficacy than sakuranetin (a known BNI), but did not inhibit AOB. Six triterpenoids showed inhibitory activity on AOA (29-100%), with 3-O-acetyl-11-keto-beta boswellic acid and 11-keto-beta boswellic acid as the most potent inhibitors (ammonia oxidation inhibition > 94%), followed by echinocystic acid (> 87%), ursolic acid (> 74%), asiatic acid (> 65%), and echinocystic acid-3-O-glucoside (29-94%). In silico analyses predicted accurately the activity of model inhibitors such as DMPP, MHPP, and ethoxyquin on AOB and AOA, respectively, and the limited activity of triterpenoids on AOB, but did not predict their strong inhibitory effects on AOA, underscoring the need for expanded datasets for model refinement. The selective activity of some triterpenoids on AOA is hypothesized to involve interference with 3-hydroxy-3-methylglutaryl-CoA reductase, a key enzyme in archaeal membrane biosynthesis, although this requires experimental validation. Still, strain-specific responses suggest the involvement of additional mechanisms. This study provides the first experimental evidence for the potential of plant-derived triterpenoids as BNIs, supporting their relevance for sustainable agriculture. KEY POINTS: • Triterpenoids strongly inhibited AOA but had no effect on AOB nitrification activity. • Six ursane/oleanane-type triterpenoids showed strong AOA inhibition beyond known BNIs. • Inhibition patterns suggest triterpenoid structure relates to AOA selectivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.